NEXT VENTŪRES
VC Fund
San Francisco, United States
NEXT VENTŪRES is a venture capital firm that invests in the sports, fitness, health, and wellness markets. With established expertise and deep connections in these markets as well as proven financial track records, the NEXT VENTŪRES team is well positioned to create significant value for their investors and their portfolio companies.The firm wasestablished in 2018 and is based in San Francisco, CA
- Total investments:
- 32
- Last investment:
- Lead investor:
- 47%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NEXT VENTŪRES invests in
Stages NEXT VENTŪRES invests in
Countries NEXT VENTŪRES invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.9M–$13M
- Series A
- $4.5M–$16M
- Series B
- $25M–$100M
Investment Focus
Industry
- Health Care 13 (41%)
- Wellness 6 (19%)
- Medical 5 (16%)
- Sports 4 (13%)
- Consumer Electronics 4 (13%)
Stage
- Seed 13 (41%)
- Series A 10 (31%)
- Series B 2 (6%)
- Funding Round 2 (6%)
- Series C 1 (3%)
Country
- United States 14 (44%)
- Canada 3 (9%)
- Finland 1 (3%)
- Thailand 1 (3%)
- Switzerland 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Julian Eison
Managing Partner
|
Managing Partner | Total investments: 4 | Find email | |
Lance Armstrong
Managing Partner and Founding Partner
|
Managing Partner and Founding Partner | Total investments: 15 | Find email | |
Melanie Strong
Founding Partner, Health and Wellness VC
|
Founding Partner, Health and Wellness VC | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Trial Library is an oncology clinical trials company. | $10M / Series A / Dec 02, 2025 | ||
| BranchLab makes healthcare advertising better so that people may find the best healthcare options. | Seed / Sep 08, 2025 | ||
| Cofertility is a human-centered fertility ecosystem that provides egg donation and egg-freezing services for fertility care and third-party reproduction. The company provides a normalized and scalable method for egg donation, which transforms the financial model of egg freezing by connecting women who wish to store their eggs with families unableto conceive otherwise. By donating half, women have the opportunity to freeze their eggs at no cost. | $7.3M / Series A / Apr 10, 2025 | ||
| With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey. | $13M / Seed / Feb 08, 2025 | ||
| Eternal offers lifetime athletes an expert team of health and performance experts to help them stay active in the sports they like for as long as possible. | $13.3M / Seed / Jan 15, 2025 | ||
| Pair Team is on a mission to build the primary care infrastructure for America’s most vulnerable communities.They are the first tech-enabled care team that empowers safety-net primary care systems and the Medicaid & Medicare patients they serve. They act as an extension of the clinical staff to provide a personalized, high-touch careexperience while addressing patients' barriers to care such as lack of transportation, housing/food insecurity, and mobile phone access. Internally, they are building a unique care delivery platform to ensure clinical best practices, integrate care with community-based organizations, and automate administrative work so that clinicians can focus on time with our patients. | $9M / Series A / Oct 19, 2023 | ||
| Vital Bio is reimagining lab testing to enable radically accessible care. Vital Bio is designing a new generation of tools to empower patients in monitoring health and managing the disease. | $48M / Jul 24, 2023 | ||
| Vital Bio is reimagining lab testing to enable radically accessible care. Vital Bio is designing a new generation of tools to empower patients in monitoring health and managing the disease. | $18M / Series A / Jul 24, 2023 | ||
| OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers. | $7M / Series A / Jan 01, 2023 | ||
| Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States. | $12M / Series A / Dec 08, 2022 | ||
| See all 32 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does NEXT VENTŪRES invest in?
NEXT VENTŪRES invests primarily in Health Care, Wellness and Medical startups, most often at Seed and Series A stage. Most of the 32 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NEXT VENTŪRES's check size?
NEXT VENTŪRES typically joins rounds of $1.9M–$13M at Seed, $4.5M–$16M at Series A and $25M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NEXT VENTŪRES participates in.
How do I contact NEXT VENTŪRES?
Public channels for NEXT VENTŪRES include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NEXT VENTŪRES?
The team at NEXT VENTŪRES includes Julian Eison (Managing Partner), Lance Armstrong (Managing Partner and Founding Partner) and Melanie Strong (Founding Partner, Health and Wellness VC). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
